Inhibition of PAI-1 accelerates venous thrombosis resolution in type II diabetic mice

被引：0
|
作者：
Li, R. [1 ]
Deng, X. [1 ]
Ren, M. [1 ]
Chen, N. [1 ]
Luo, M. [1 ]
Yan, K. [1 ]
Zeng, M. [1 ]
Wu, J. [1 ]
机构：
[1] Luzhou Med Coll, Drug Discovery Res Ctr, Luzhou, Peoples R China
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2015年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AS147
引用
收藏
页码：53 / 53
页数：1
相关论文
共 50 条
  • [41] Effect of 4G/5G PAI-1 polymorphism on the response of PAI-1 activity to vitamin E supplementation in Type 2 diabetic patients
    Testa, R
    Bonfigli, AR
    Sirolla, C
    Boemi, M
    Manfrini, S
    Mari, D
    Testa, I
    Sacchi, E
    Franceschi, C
    DIABETES NUTRITION & METABOLISM, 2004, 17 (04) : 217 - 221
  • [42] A strong inverse relationship between PAI-1 and Lp(a) in hypertensive Type 2 diabetic patients
    Testa, R
    Bonfigli, AR
    Sirolla, C
    Marra, M
    Antonicelli, R
    Manfrini, S
    Compagnucci, P
    Testa, I
    DIABETES NUTRITION & METABOLISM, 1999, 12 (06) : 400 - 406
  • [43] Food deprivation induces adipose plasminogen activator inhibitor-1 (PAI-1) expression without accumulation of plasma PAI-1 in genetically obese and diabetic db/db mice
    Oishi, Katsutaka
    Ohkura, Naoki
    Matsuda, Juzo
    Ishida, Norio
    THROMBOSIS AND HAEMOSTASIS, 2007, 98 (04) : 864 - 870
  • [44] The effect of metformin treatment on VEGF and PAI-1 Levels in obese type 2 diabetic patients
    Ersoy, Canan
    Kiyici, Sinem
    Budak, Ferah
    Oral, Barbaros
    Guclu, Metin
    Duran, Cevdet
    Selimoglu, Hadi
    Erturk, Erdinc
    Tuncel, Ercan
    Imamoglu, Sazi
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 81 (01) : 56 - 60
  • [45] Microangiopathic injury and augmented PAI-1 in human diabetic nephropathy
    Paueksakon, P
    Revelo, MP
    Ma, LJ
    Marcantoni, C
    Fogo, AB
    KIDNEY INTERNATIONAL, 2002, 61 (06) : 2142 - 2148
  • [46] ELISA for complexes of urokinase-type and tissue-type plasminogen activators with their type-1 inhibitor (uPA∼PAI-1 and tPA∼PAI-1)
    Grebenschikov, N
    Sweep, F
    Geurts, A
    Andreasen, P
    De Witte, H
    Schousboe, S
    Heuvel, J
    Benraad, T
    INTERNATIONAL JOURNAL OF CANCER, 1999, 81 (04) : 598 - 606
  • [47] Active PAI-1 as marker for venous thromboembolism: Case-control study using a comprehensive panel of PAI-1 and TAFI assays
    Bollen, Lize
    Peetermans, Marijke
    Peeters, Miet
    Van Steen, Kristel
    Hoylaerts, Marc F.
    Declerck, Paul J.
    Verhamme, Peter
    Gils, Ann
    THROMBOSIS RESEARCH, 2014, 134 (05) : 1097 - 1102
  • [48] Pivotal role of PAI-1 in a murine model of hepatic vein thrombosis
    Smith, LH
    Dixon, JD
    Stringham, JR
    Eren, M
    Elokdah, H
    Crandall, DL
    Washington, K
    Vaughan, DE
    BLOOD, 2006, 107 (01) : 132 - 134
  • [49] The Central Role of PAI-1 in COVID-19: Thrombosis and beyond
    Khan, Sadiya S.
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2021, 65 (03) : 238 - 240
  • [50] Compound interest: ACE and PAI-1 polymorphisms and risk of thrombosis and fibrosis
    Fogo, AB
    Vaughan, DE
    KIDNEY INTERNATIONAL, 1998, 54 (05) : 1765 - 1766
12345